Horizon Pharma PLC Alpha and Beta Analysis

HZNPDelisted Stock  USD 116.30  0.00  0.00%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Horizon Pharma PLC. It also helps investors analyze the systematic and unsystematic risks associated with investing in Horizon Pharma over a specified time horizon. Remember, high Horizon Pharma's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Horizon Pharma's market risk premium analysis include:
Beta
0.0492
Alpha
0.18
Risk
0.0
Sharpe Ratio
0.0
Expected Return
0.0
Please note that although Horizon Pharma alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., NYSE Composite index.) So in this particular case, Horizon Pharma did 0.18  better than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Horizon Pharma PLC stock's relative risk over its benchmark. Horizon Pharma PLC has a beta of 0.05  . As returns on the market increase, Horizon Pharma's returns are expected to increase less than the market. However, during the bear market, the loss of holding Horizon Pharma is expected to be smaller as well. .
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.

Horizon Pharma Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Horizon Pharma market risk premium is the additional return an investor will receive from holding Horizon Pharma long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Horizon Pharma. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Horizon Pharma's performance over market.
α0.18   β0.05

Horizon Pharma Fundamentals Vs Peers

Comparing Horizon Pharma's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Horizon Pharma's direct or indirect competition across all of the common fundamentals between Horizon Pharma and the related equities. This way, we can detect undervalued stocks with similar characteristics as Horizon Pharma or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Horizon Pharma's fundamental indicators could also be used in its relative valuation, which is a method of valuing Horizon Pharma by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Horizon Pharma to competition
FundamentalsHorizon PharmaPeer Average
Return On Equity0.0854-0.31
Return On Asset0.0444-0.14
Profit Margin0.12 %(1.27) %
Operating Margin0.18 %(5.51) %
Current Valuation26.87 B16.62 B
Shares Outstanding229 M571.82 M
Shares Owned By Insiders1.18 %10.09 %

Horizon Pharma Opportunities

Horizon Pharma Return and Market Media

The Stock received a lot of media exposure during the period.
 Price Growth (%)  
       Timeline  
1
Rule 8.1 Dealing Disclosure
07/28/2023
2
Horizon Therapeutics Public Issues Earnings Results
08/10/2023
3
George Soros has a big stake in this stock but its posted a roughly 9 percent loss this year. Are there lessons in this for regular investors
08/16/2023
4
Horizon Therapeutics plc Ranks First in Overall Corporate Reputation by Rare Disease Patient Advocacy Groups
08/23/2023
5
Horizon Up as FTC Pauses Acquisition by Amgen Lawsuit
08/28/2023
6
Toronto Dominion Bank Buys 185,145 Shares of Horizon Therapeutics Public Limited
08/30/2023
7
U.S. FTC allows Amgen to move forward with 27.8 bln Horizon deal - CNBC - Marketscreener.com
09/01/2023
8
Horizon Therapeutics plc Rule 2.12 Announcement
09/06/2023
9
Institutional owners may consider drastic measures as Vir Biotechnology, Inc.s recent US85m drop adds to long-term losses - Simply Wall St
09/21/2023
10
Disposition of 110447 shares by Thomas Watkins of Horizon Pharma subject to Rule 16b-3
10/06/2023

About Horizon Pharma Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Horizon or other delisted stocks. Alpha measures the amount that position in Horizon Pharma PLC has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.

Horizon Pharma Upcoming Company Events

As portrayed in its financial statements, the presentation of Horizon Pharma's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Horizon Pharma's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Horizon Pharma's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Horizon Pharma. Please utilize our Beneish M Score to check the likelihood of Horizon Pharma's management manipulating its earnings.
1st of November 2023
Upcoming Quarterly Report
View
6th of March 2024
Next Financial Report
View
30th of September 2023
Next Fiscal Quarter End
View
6th of March 2024
Next Fiscal Year End
View
30th of June 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Build Portfolio with Horizon Pharma

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Other Consideration for investing in Horizon Stock

If you are still planning to invest in Horizon Pharma PLC check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Horizon Pharma's history and understand the potential risks before investing.
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Bonds Directory
Find actively traded corporate debentures issued by US companies
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Transaction History
View history of all your transactions and understand their impact on performance
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.